MediFind

Find a Doctor

Richard Delarue

Hôpital Necker
Male

Bio


Richard Delarue is in Paris, France. They have been an author on 106 peer reviewed articles in the past 15 years. Dr. Delarue's top three areas of expertise are Angioimmunoblastic T-cell Lymphoma, Non-Hodgkin Lymphoma, and Lymphofollicular Hyperplasia.

Contact

Paris, FR

Latest Research


Latest Advance
Study
  • Condition: Relapsed/Refractory Hematologic Malignancies
  • Journal: Clinical lymphoma, myeloma & leukemia
  • Treatment Used: Tenalisib
  • Number of Patients: 35
  • Published —
This study evaluated the safety and effectiveness of tenalisib in patients with relapsed/refractory hematologic malignancies.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Paris, FR

Insurance

Contact them to find out if they accept your insurance plan.